Epidemiology-based wastewater monitoring for ecological risks of anti-tuberculosis drugs mixture effects

被引:2
|
作者
Chen, Wei -Yu [1 ]
Chen, Yi-Fang [2 ]
Tsai, Jer-Min [3 ]
Huang, Hsin-Mei [1 ]
Su, Yong -Chao [2 ]
机构
[1] Natl Univ Tainan, Dept Ecol & Environm Resources, Tainan, Taiwan
[2] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan
[3] Kun Shan Univ, Dept Informat & Commun, Tainan, Taiwan
关键词
Anti -tuberculosis drugs; Mixture toxicity; Daphnia magna; Epidemic models; Ecotoxicological risk; PULMONARY TUBERCULOSIS; SEASONALITY; TOXICITY; RIFAMPICIN; ETHAMBUTOL; ANTIBIOTICS; INFLUENZA; HEPATOTOXICITY; NEUROTOXICITY; HEPATOCYTES;
D O I
10.1016/j.scitotenv.2023.164560
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
First-line anti-tuberculosis (TB) drugs are commonly used to treat TB worldwide, leading to more contaminated wastewater being widely discharged into aquatic environments. However, studies of mixture interactions of anti-TB drugs and their residues in aquatic environments are scarce. This study aimed to determine the toxic interactions of antiTB drugs-isoniazid (INH), rifampicin (RMP), and ethambutol (EMB)-in binary and ternary mixtures on Daphnia magna and used the epidemiology of TB history to construct epidemiology-based wastewater monitoring for assessing the environmental release of residues and related ecological risks. The acute immobilization of median effect concentrations (EC50) was 25.6 mg L-1 for INH, 80.9 mg L-1 for RMP, and 188.8 mg L-1 for EMB, as toxic units (TUs) for assessing mixture toxicity. The ternary mixture exhibited the lowest TUs at 50 % effects with 1.12, followed by 1.28 for RMP + EMB, 1.54 for INH + RMP, and 1.93 for INH + EMB, indicating antagonistic interactions. Nevertheless, the combination index (CBI) was used to examine the mixture toxicity in response to immobilization, revealing that the ternary mixture of CBI ranged from 1.01 to 1.08, tending to have a nearly additive effect when suffering >50 % effect (at high concentration levels). The forecasted environmentally relevant concentrations of anti-TB drugs have been on downward trends with ng L-1 level from 2020 to 2030 in Kaohsiung, Taiwan. Although ecotoxicological risks from the wastewater treatment plant and receiving water in the field were slightly greater than the prediction from epidemiology-based wastewater monitoring, there were no risk concerns. Here, we achieved the establishment of evidence that anti-TB drug mixtures' interaction and epidemiological-based monitoring support a systematic approach, resolving the absence of the mixture toxicity information for anti-TB mixture risk assessment in aquatic environments.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] The epidemiology of tuberculosis and resistance to anti-tuberculosis drugs
    Khaled, NA
    Enarson, D
    Billo, N
    REVUE DES MALADIES RESPIRATOIRES, 1997, 14 : S8 - S18
  • [2] World epidemiology of tuberculosis and resistance against anti-tuberculosis drugs
    Grosset, J
    Zunic, L
    Morcrette, C
    ANNALES DE MEDECINE INTERNE, 2002, 153 (02): : 107 - 112
  • [3] ADVERSE-EFFECTS OF ANTI-TUBERCULOSIS DRUGS
    GIRLING, DJ
    DRUGS, 1982, 23 (1-2) : 56 - 74
  • [4] Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs
    Kuhlin, Johanna
    Sturkenboom, Marieke G. G.
    Ghimire, Samiksha
    Margineanu, Ioana
    van den Elsen, Simone H. J.
    Simbar, Noviana
    Akkerman, Onno W.
    Jongedijk, Erwin M.
    Koster, Remco A.
    Bruchfeld, Judith
    Touw, Daan J.
    Alffenaar, Jan-Willem C.
    CLINICAL MASS SPECTROMETRY, 2019, 14 : 34 - 45
  • [5] Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia
    Lisdawati, Vivi
    Puspandari, Nelly
    Rif'ati, Lutfah
    Soekarno, Triyani
    Melatiwati, M.
    Syamsidar, K.
    Ratnasari, Lies
    Izzatun, Nur
    Parwati, Ida
    BMC INFECTIOUS DISEASES, 2015, 15
  • [6] Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia
    Vivi Lisdawati
    Nelly Puspandari
    Lutfah Rif’ati
    Triyani Soekarno
    Melatiwati M
    Syamsidar K
    Lies Ratnasari
    Nur Izzatun
    Ida Parwati
    BMC Infectious Diseases, 15
  • [7] CYTOGENETIC EFFECTS OF SOME ANTI-TUBERCULOSIS DRUGS INVITRO
    ROMAN, IC
    GEORGIAN, L
    MUTATION RESEARCH, 1977, 48 (02): : 215 - 224
  • [8] Adverse effects of anti-tuberculosis drugs in hemodialysis patients
    Gordeeva, Olga
    Karpina, Natalya
    Vedernikova, Raisa
    Schultz, Inna
    Bagdasarian, Anna
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [9] SIDE-EFFECTS AND INTERACTIONS OF ANTI-TUBERCULOSIS DRUGS
    ADDINGTON, WW
    CHEST, 1979, 76 (06) : 782 - 784
  • [10] Monitoring the ingestion of anti-tuberculosis drugs by simple non-invasive methods
    Sirgel, FA
    Maritz, JS
    Venter, A
    Langdon, G
    Smith, PJ
    Donald, PR
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 307 (02) : 182 - 187